Volume 93, Issue 6 pp. e516-e517
Letter to the Editor
Free Access

Ranibizumab in the treatment of choroidal neovascularization associated with morning glory syndrome

Gilda Cennamo

Corresponding Author

Gilda Cennamo

Eye Clinic, Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy

Correspondence:

Gilda Cennamo, MD

Eye Clinic

Department of Neurosciences, Reproductive Sciences and Dentistry

University of Naples Federico II

Via Pansini 5, Naples 80100

Italy

Tel: +39 0817463731

Fax: +39 0817462383

Email: [email protected]

Search for more papers by this author
Claudia Rossi

Claudia Rossi

Eye Clinic, Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy

Search for more papers by this author
Nunzio Velotti

Nunzio Velotti

Eye Clinic, Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy

Search for more papers by this author
Giuseppe de Crecchio

Giuseppe de Crecchio

Eye Clinic, Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy

Search for more papers by this author
First published: 01 March 2015
Citations: 4
Editor,

Morning glory syndrome (MGS) is a congenital dysplasia characterized by anestesia of the posterior pole involving the optic disc (Kindler 1970). Retinal detachment is common in MGS and is ascribed to abnormal communication between the subretinal and subarachnoid or vitreous compartments (Cennamo et al. 2010). Indeed, choroidal neovascularization (CNV) is a rare complication in this disease. Here, we report, a case of juxtapapillary choroidal neovascularization in MGS treated with intravitreal ranibizumab.

A 63-year-old white woman presented with a 4-week history of decreased vision in her left eye. Best-corrected visual acuity (BCVA) was 0 logMar in the right eye and 0.7 logMar in the left eye. The anterior segment examination was normal in both eyes. Fundus examination was normal in the right eye and revealed MGS with subretinal haemorrhage adjacent to the optic disc, suggesting CNV in the left eye (Fig. 1A). Fluorescein angiography and indocyanine green angiography confirmed the CNV (Fig. 1B,C). Spectral-domain optical coherence tomography (SD-OCT) (RTVue-100 Optovue Inc, Fremont, CA, USA) showed a hyper-reflective mass in the subretinal space associated with a neurosensory detachment (Fig. 1E). It also revealed an abnormal communication between the subarachnoid space and the vitreous space (Fig. 1F). Standardized echography showed excavation of the posterior pole and a normal optic nerve (Fig. 1D).

Details are in the caption following the image
Baseline evaluation of the left eye. (A) Multicolour image showing morning glory syndrome with glial tissue overlying the optic disc cup and subretinal haemorrhage. (B) Fluorescein angiography revealed late-stage peripapillary neovascularization. (C) Indocyanine green angiography revealed hyperfluorescence of the lesion. (D) B-scan echography showed conical excavation of the posterior pole (arrow). (E) Spectral-domain optical coherence tomography (SD-OCT) showed subretinal tissue proliferation with subretinal fluid in the peripapillary area. (F) SD-OCT showed an abnormal communication between the subarachnoid space and vitreous space. (G–I) Multicolour image, fluorescein angiography and indocyanine green angiography, respectively, showing total regression of the CNV after four months of treatment. (J) SD-OCT revealed complete resolution of the subretinal fluid.

After obtaining informed consent, we administered three monthly intravitreal injections of ranibizumab in the left eye. After 4 months, BCVA improved to 0.1 logMar. Fundus examination revealed resolution of the subretinal haemorrhage (Fig. 1G). Fluorescein angiography and indocyanine green angiography showed total regression of the CNV (Fig. 1H,I). The SD-OCT did not reveal subretinal fluid (Fig. 1J). These findings remained unchanged during the 24-month follow-up.

To our knowledge, this is the first report to show efficacy of ranibizumab in the treatment of juxtapapillary CNV in MGS. Choroidal neovascularization is a rare complication in eyes with MGS. Two cases of subretinal neovascular membranes associated with MGS have been described (Sobol et al. 1990; Chuman et al. 1996), and in only one of these cases was it adjacent to the optic disc.

This case report suggests that CNV in eyes affected by MGS may result from hemodynamic or mechanical changes at the border of the staphyloma as occurs in tilted disc syndrome (Arias & Monés 2010).

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.